Maria Donata Benedetti

Summary

Publications

  1. pmc Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients?
    Alberto Gajofatto
    Section of Clinical Neurology, Department of Neurological, Neuropsychological, Morphological and Motor Sciences, University of Verona, Verona 37129, Italy E mail
    Int J Mol Sci 12:7960-70. 2011
  2. doi request reprint Benign course of tumour-like multiple sclerosis. Report of five cases and literature review
    Marco Turatti
    The Section of Clinical Neurology, Department of Neurological, Neuropsychological, Morphological and Motor Sciences, University of Verona, Italy
    J Neurol Sci 324:156-62. 2013
  3. pmc Clinical, MRI, and CSF markers of disability progression in multiple sclerosis
    Alberto Gajofatto
    Section of Clinical Neurology, Department of Neurological and Movement Sciences, University of Verona, Neurology Unit, Borgo Roma, Azienda Ospedaliera Universitaria Integrata Verona, Piazzale Ludovico Antonio Scuro 9, 37134 Verona, Italy
    Dis Markers 35:687-99. 2013
  4. ncbi request reprint Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases
    Alberto Gajofatto
    Section of Clinical Neurology, Department of Neurological and Vision Sciences, University of Verona, Piazzale LA Scuro 10, 37134 Verona, Italy
    Arch Neurol 67:724-30. 2010
  5. doi request reprint Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis
    Michele Fiorini
    Section of Clinical Neurology, Department of Neurological and Visual Sciences, University of Verona, Verona, Italy
    Proteomics Clin Appl 1:963-71. 2007

Collaborators

Detail Information

Publications5

  1. pmc Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients?
    Alberto Gajofatto
    Section of Clinical Neurology, Department of Neurological, Neuropsychological, Morphological and Motor Sciences, University of Verona, Verona 37129, Italy E mail
    Int J Mol Sci 12:7960-70. 2011
    ..However, none has shown sufficient reproducibility to be applied in clinical practice. Here we review the current literature addressing the above mentioned biomarkers as MS severity predictors at an early stage...
  2. doi request reprint Benign course of tumour-like multiple sclerosis. Report of five cases and literature review
    Marco Turatti
    The Section of Clinical Neurology, Department of Neurological, Neuropsychological, Morphological and Motor Sciences, University of Verona, Italy
    J Neurol Sci 324:156-62. 2013
    ..Multiple sclerosis (MS) with initial neuroradiological features suggestive of brain tumour (tumour-like MS) may represent a challenging diagnosis...
  3. pmc Clinical, MRI, and CSF markers of disability progression in multiple sclerosis
    Alberto Gajofatto
    Section of Clinical Neurology, Department of Neurological and Movement Sciences, University of Verona, Neurology Unit, Borgo Roma, Azienda Ospedaliera Universitaria Integrata Verona, Piazzale Ludovico Antonio Scuro 9, 37134 Verona, Italy
    Dis Markers 35:687-99. 2013
    ..Current relevant literature addressing the topic of clinical, MRI, and CSF markers as predictors of MS disability progression is reviewed here. ..
  4. ncbi request reprint Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases
    Alberto Gajofatto
    Section of Clinical Neurology, Department of Neurological and Vision Sciences, University of Verona, Piazzale LA Scuro 10, 37134 Verona, Italy
    Arch Neurol 67:724-30. 2010
    ..To identify predictors of short- and long-term outcomes in acute myelitis (AM)...
  5. doi request reprint Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis
    Michele Fiorini
    Section of Clinical Neurology, Department of Neurological and Visual Sciences, University of Verona, Verona, Italy
    Proteomics Clin Appl 1:963-71. 2007
    ..To the best of our knowledge, this is the first time in which such a panel of biomarkers is reported in MS...